Comparative study of analgesic effectiveness using three different anesthetic techniques for intravitreal injection of bevacizumab.

Abstract

BACKGROUND AND OBJECTIVE:

To compare the analgesic effectiveness and aesthetic appearance associated with topical, subconjunctival, and peribulbar anesthesia for intravitreal bevacizumab injection.

PATIENTS AND METHODS:

Sixty consecutive patients undergoing their first intravitreal bevacizumab injection were randomized to receive one of three forms of anesthesia: proxymetacaine eye drops, subconjunctival injection of 2% xylocaine, and peribulbar injection of 2% xylocaine. Pain associated with the intravitreal injection and with the entire procedure (including anesthesia administration) was recorded using a Visual Analog Scale 15 minutes after intravitreal injection. Anterior segment evaluation was performed 24 hours after injection to measure the number of clock hours of subconjunctival hemorrhage.

RESULTS:

Median injection-related pain score was significantly lower in the peribulbar group compared with the topical and subconjunctival groups (P < .05). Median entire procedure pain score was significantly higher in the peribulbar group compared with the topical and subconjunctival groups (P < .05). The median extent of subconjunctival hemorrhage was significantly lower in the topical group compared with the other groups (P < .05).

CONCLUSION:

Among the three anesthetic techniques, peribulbar anesthesia was associated with greater effectiveness in controlling injection-related pain but was least effective in controlling entire procedure pain. There was no significant difference in pain scores between the topical and subconjunctival groups, and topical anesthesia was associated with less subconjunctival hemorrhage.

• Authors: Léssia P Cintra, Levy R Lucena, José A Da Silva, Rogério A Costa, Ingrid U Scott, Rodrigo Jorge
• Journal: Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye (Ophthalmic Surg Lasers Imaging) 2009 Jan-Feb Vol. 40 Issue 1 Pg. 13-8 ISSN: 1542-8877 [Print] United States
• PMID: 19205490 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)

Chemical References

• Anesthetics, Local
• Angiogenesis Inhibitors
• Antibodies, Monoclonal
• Antibodies, Monoclonal, Humanized
• Bevacizumab
• Lidocaine
• proxymetacaine
• Propoxycaine

Topics

• Analgesia (methods)
• Anesthesia, Local (methods)
• Anesthetics, Local (administration & dosage)
• Angiogenesis Inhibitors (administration & dosage)
• Antibodies, Monoclonal (administration & dosage)
• Antibodies, Monoclonal, Humanized
• Bevacizumab
• Female
• Humans
• Injections
• Lidocaine (administration & dosage)
• Male
• Middle Aged
• Pain (diagnosis, prevention & control)
• Pain Measurement
• Propoxycaine (administration & dosage)
• Vitreous Body